Fig. 2
From: Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
Use of SGLT2 inhibitors or GLP-1 receptor agonists by patient factors according to the hierarchical logistic regression model
Fig. 2 | BMC Endocrine Disorders